SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001125282-06-004989
Filing Date
2006-08-14
Accepted
2006-08-14 14:11:14
Documents
8
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q p414461_10q.htm 10-Q 623527
2 GRAPHIC emptybox.gif GRAPHIC 861
3 GRAPHIC tickedbox.gif GRAPHIC 897
4 EXHIBIT 10.2 p414461_ex10-2.htm EX-10.2 379579
5 GRAPHIC a04img1.jpg GRAPHIC 68523
6 EXHIBIT 31.1 p414461_ex31-1.htm EX-31.1 10456
7 EXHIBIT 31.2 p414461_ex31-2.htm EX-31.2 10481
8 EXHIBIT 32.1 p414461_ex32-1.htm EX-32.1 8878
  Complete submission text file 0001125282-06-004989.txt   1131901
Mailing Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341
Business Address 707 EAGLEVIEW BOULEVARD SUITE 414 EXTON PA 19341 610-458-6200
ANTARES PHARMA INC (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 061028960
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10